1,010
Participants
Start Date
February 2, 2010
Primary Completion Date
February 5, 2013
Study Completion Date
March 7, 2017
Cetuximab
Administered by intravenous infusion
Panitumumab
Administered by intravenous infusion
Research Site, Lima
Research Site, Lima
Research Site, Manila
Research Site, Riga
Research Site, Riga
Research Site, Quezon City
Research Site, Sofia
Research Site, Sofia
Research Site, St Leonards
Research Site, Wahroonga
Research Site, Liverpool
Research Site, Johannesburg
Research Site, Johannesburg
Research Site, Wollongong
Research Site, Edegem
Research Site, Footscray
Research Site, Parkville
Research Site, Epping
Research Site, Heidelberg
Research Site, Box Hill
Research Site, Ballarat
Research Site, Woodville South
Research Site, Daugavpils
Research Site, Cebu City
Research Site, Port Elizabeth
Research Site, Kraaifontein
Research Site, Torino
Research Site, Taipei
Research Site, Genova
Research Site, Kota Bharu
Research Site, Niš
Research Site, Keelung
Research Site, Kamenitz
Research Site, Saint-Brieuc
Research Site, Besançon
Research Site, Montbéliard
Research Site, Cremona
Research Site, Taoyuan District
Research Site, Boynton Beach
Research Site, Kfar Saba
Research Site, Saint-Herblain
Research Site, Meldola FC
Research Site, Cesena
Research Site, Rimini
Research Site, Faenza RA
Research Site, Lugo
Research Site, Ravenna
Research Site, Kaunas
Research Site, Ramat Gan
Research Site, Kuala Lumpur
Research Site, Kuala Lumpur
Research Site, Ancona
Research Site, Putzu City
Research Site, Beersheba
Research Site, Wichita
Research Site, Tainan City
Research Site, Rehovot
Research Site, Temple
Research Site, Ogden
Research Site, Kota Kinabalu
Research Site, Jerusalem
Research Site, Villejuif
Research Site, Stockton
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Moscow
Research Site, Moscow
Research Site, Singapore
Research Site, Changchun
Research Site, Harbin
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Tianjin
Research Site, Singapore
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Chongqing
Research Site, Changsha
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Sibiu
Research Site, Chengdu
Research Site, Xi'an
Research Site, Edmonton
Research Site, Halifax
Research Site, Hořovice
Research Site, Nová Ves pod Pleší
Research Site, Olomouc
Research Site, Prague
Research Site, Příbram
Research Site, Znojmo
Research Site, Kowloon
Research Site, New Territories
Research Site, Hyderabad
Research Site, Hyderabad
Research Site, Kochi
Research Site, Ahilyanagar
Research Site, Nagpur
Research Site, Nashik
Research Site, Nashik
Research Site, Pune
Research Site, Jaipur
Research Site, Chennai
Research Site, Kolkata
Research Site, Vilnius
Research Site, Rotterdam
Research Site, Lima
Research Site, Elblag
Research Site, Gdansk
Research Site, Jelenia Góra
Research Site, Poznan
Research Site, Szczecin
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Bucharest
Research Site, Bardejov
Research Site, Bratislava
Research Site, Nitra
Research Site, Groenkloof
Research Site, Goyang-si, Gyeonggi-do
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Gothenburg
Research Site, Linköping
Research Site, Lund
Research Site, Uppsala
Research Site, Vaxjo
Research Site, Västerås
Research Site, Belfast
Research Site, Bristol
Research Site, Cardiff
Research Site, Guildford
Research Site, Leicester
Research Site, London
Research Site, Maidstone
Research Site, Manchester
Research Site, Oxford
Research Site, Sutton
Research Site, Wolverhampton
Lead Sponsor
Amgen
INDUSTRY